We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Alibaba, Medtronic, Schlumberger, Cisco Systems and Moody's
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 11, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alibaba Group Holding Ltd. (BABA - Free Report) , Medtronic plc (MDT - Free Report) , Schlumberger Ltd. (SLB - Free Report) , Cisco Systems, Inc. (CSCO - Free Report) and Moody's Corp. (MCO - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Alibaba, Medtronic and Schlumberger
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd. (BABA - Free Report) , Medtronic plc (MDT - Free Report) and Schlumberger Ltd. (SLB - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Alibaba have gained +2.8% over the year-to-date period against the Zacks Internet - Commerce industry's gain of +31.9%. The company's solid momentum across the international commerce retail businesses is driving its top-line growth. Strength in Trendyol, Lazada and AliExpress continues to contribute well.
Additionally, solid momentum across financial services, education and automobile industries remains a positive for the company's cloud business. This apart, strength across the local consumer services and Cainiao logistics services, Alibaba Health and Freshippo is contributing well.
However, uncertainties associated with coronavirus pandemic remain major concerns, especially for Alibaba's domestic businesses. Sluggish China commerce business is a concern. Additionally, softness in the digital media business is a headwind. Rising expenses associated with new initiatives are overhangs.
Medtronic shares have outperformed the Zacks Medical - Products industry over the past six months (+8.7% vs. +1.5%). The company is strategically expanding its global presence to address the unmet demand for advanced medical technologies.
Within Cardiovascular, Medtronic is gaining market share, banking on product launches. Within MedSurg, Medtronic is scaling production of Hugo RAS. Innovations and market expansion efforts are helping it offset the impact of the inflation and supply disruptions.
However, Medtronic's strong liquidity position should allow it to meet its near-term debt obligations. All these factors support our bullish stance on the stock.
Shares ofSchlumberger have outperformed the Zacks Oil and Gas - Field Services industry over the past year (+62.8% vs. +44.3%). The company is a well-known name for providing diversified oilfield services and products to companies belonging to the energy sector. Being the leading provider of technology for complex oilfields, the firm is well-poised to take up new offshore projects in international markets.
SLB expects upstream spending across the globe to continue growing, which in turn could increase demand for well completion activities. With broad-based growth in overall activities, SLB expects to benefit from increased service pricing.
However, the cost of revenue continues to rise, affecting its income statement. Moreover, declining operating cashflows is a concern. Also, the aggressive capital budget remains a headwind for the company. SLB's overall business is highly vulnerable to extreme commodity price volatility. As such, the stock warrants a cautious stance.
Other noteworthy reports we are featuring today include Cisco Systems, Inc. and Moody's Corp..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Alibaba, Medtronic, Schlumberger, Cisco Systems and Moody's
For Immediate Release
Chicago, IL – July 11, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alibaba Group Holding Ltd. (BABA - Free Report) , Medtronic plc (MDT - Free Report) , Schlumberger Ltd. (SLB - Free Report) , Cisco Systems, Inc. (CSCO - Free Report) and Moody's Corp. (MCO - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Alibaba, Medtronic and Schlumberger
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Ltd. (BABA - Free Report) , Medtronic plc (MDT - Free Report) and Schlumberger Ltd. (SLB - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Alibaba have gained +2.8% over the year-to-date period against the Zacks Internet - Commerce industry's gain of +31.9%. The company's solid momentum across the international commerce retail businesses is driving its top-line growth. Strength in Trendyol, Lazada and AliExpress continues to contribute well.
Additionally, solid momentum across financial services, education and automobile industries remains a positive for the company's cloud business. This apart, strength across the local consumer services and Cainiao logistics services, Alibaba Health and Freshippo is contributing well.
However, uncertainties associated with coronavirus pandemic remain major concerns, especially for Alibaba's domestic businesses. Sluggish China commerce business is a concern. Additionally, softness in the digital media business is a headwind. Rising expenses associated with new initiatives are overhangs.
(You can read the full research report on Alibaba here >>>)
Medtronic shares have outperformed the Zacks Medical - Products industry over the past six months (+8.7% vs. +1.5%). The company is strategically expanding its global presence to address the unmet demand for advanced medical technologies.
Within Cardiovascular, Medtronic is gaining market share, banking on product launches. Within MedSurg, Medtronic is scaling production of Hugo RAS. Innovations and market expansion efforts are helping it offset the impact of the inflation and supply disruptions.
However, Medtronic's strong liquidity position should allow it to meet its near-term debt obligations. All these factors support our bullish stance on the stock.
(You can read the full research report on Medtronic here >>>)
Shares ofSchlumberger have outperformed the Zacks Oil and Gas - Field Services industry over the past year (+62.8% vs. +44.3%). The company is a well-known name for providing diversified oilfield services and products to companies belonging to the energy sector. Being the leading provider of technology for complex oilfields, the firm is well-poised to take up new offshore projects in international markets.
SLB expects upstream spending across the globe to continue growing, which in turn could increase demand for well completion activities. With broad-based growth in overall activities, SLB expects to benefit from increased service pricing.
However, the cost of revenue continues to rise, affecting its income statement. Moreover, declining operating cashflows is a concern. Also, the aggressive capital budget remains a headwind for the company. SLB's overall business is highly vulnerable to extreme commodity price volatility. As such, the stock warrants a cautious stance.
(You can read the full research report on Schlumberger here >>>)
Other noteworthy reports we are featuring today include Cisco Systems, Inc. and Moody's Corp..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.